Search results
Jump to navigation
Jump to search
- class of diseases that involve the heart or blood vessels14 statements, 0 sitelinks - 16:45, 20 June 2023
- congenital, inherited, or acquired anomalies of the cardiovascular system, including the heart and blood vessels3 statements, 0 sitelinks - 20:39, 21 December 2023
- biological system including the heart and vasculature3 statements, 0 sitelinks - 16:40, 20 June 2023
- surgical procedure that makes a temporary cut or incision in the cardiovascular system1 statement, 0 sitelinks - 19:37, 29 June 2023
- 2 statements, 0 sitelinks - 12:00, 4 December 2023
- rare form of cardiovascular disease4 statements, 0 sitelinks - 20:41, 21 December 2023
- three independent systems that work together: cardiovascular, pulmonary and systemic5 statements, 0 sitelinks - 17:04, 30 April 2023
- symptom4 statements, 0 sitelinks - 17:58, 20 June 2023
- cardiovascular system disease that primarily affects the blood vessels5 statements, 0 sitelinks - 16:48, 20 June 2023
- branch of medicine dealing with disorders of the heart as well as parts of the circulatory system8 statements, 1 sitelink - 12:46, 4 March 2024
- cardiovascular system disease that is located in the fibrous sac surrounding the heart8 statements, 0 sitelinks - 23:15, 30 December 2023
- cardiovascular system disease that involves the heart7 statements, 0 sitelinks - 16:44, 20 June 2023
- [[File:Renin-angiotensin system in man shadow.svg|thumb|250px|RASの解剖図]] ...trolyte/ja|電解質]]バランス、および全身の[[vascular resistance/ja|血管抵抗]]を調節する[[endocrine system/ja|ホルモン系]]である。 ...15 KB (558 words) - 09:29, 28 March 2024
- {{Short description|Hormone system}} [[File:Renin-angiotensin system in man shadow.svg|thumb|250px|Anatomical diagram of RAS]] ...12 KB (1,713 words) - 09:17, 27 March 2024
- {{Short description|Hormone system}} [[File:Renin-angiotensin system in man shadow.svg|thumb|250px|Anatomical diagram of RAS]] ...12 KB (1,757 words) - 09:15, 27 March 2024
- ...ssociation/ja|米国糖尿病学会]]の医療標準では、GLP-1作動薬は2型糖尿病の第一選択薬として、特に[[atherosclerotic cardiovascular disease/ja|動脈硬化性心血管病]]または[[obesity/ja|肥満]]を有する患者に推奨されている。 ...a|非アルコール性脂肪肝疾患]]、[[polycystic ovary syndrome/ja|多嚢胞性卵巣症候群]]、依存症などの[[reward system/ja|報酬系]]の疾患など、他の適応症についても開発が進められている。 ...17 KB (521 words) - 16:46, 13 April 2024
- メタボリックシンドロームは、[[cardiovascular disease/ja|心血管疾患]]や[[diabetes mellitus type 2/ja|2型糖尿病]]の発症リスクと関連している。米国では、 ...|医学研究]]の分野である。研究者たちは、メタボリックシンドロームの診断が鑑別治療を意味するのか、あるいは個々の構成要素の合計から示唆される以上に[[cardiovascular disease/ja|心血管系疾患]]のリスクを増大させるのかについて議論している。 ...29 KB (700 words) - 19:30, 28 February 2024
- {{Short description|Drug classification system}} ...mmendation]] or [[efficacy]].<ref>{{cite web |title=Purpose of the ATC/DDD system |url=https://www.whocc.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system ...14 KB (2,014 words) - 17:11, 3 January 2023
- ...ver disease]], [[polycystic ovary syndrome]], and diseases of the [[reward system]] such as addictions. ...2 diabetes in patients who have or are at high risk for [[atherosclerotic cardiovascular disease]] or [[heart failure]]. They are also a first line treatment for pe ...13 KB (1,847 words) - 16:47, 13 April 2024
- {{See also|Organ system}} .... A biological system is not to be confused with a [[Living systems|living system]], such as a living [[organism]]. ...10 KB (1,310 words) - 08:01, 4 January 2023